Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mochida Pharmaceutical Co., Ltd.

http://www.mochida.co.jp/english/

Latest From Mochida Pharmaceutical Co., Ltd.

Astellas CStO Pearson: We’re Not Short Of Opportunities To Compensate For LOEs

Astellas’ chief strategy officer, Adam Pearson, talks to Scrip about the company’s launch execution thrust for key therapies ahead of the loss of exclusivity for Xtandi and also deal-making appetite and choices, including the Iveric Bio buyout and walking away from the collaboration with Cartesian Therapeutics.

Commercial Business Strategies

Merck KGaA Looks To Build Cancer ADCs With Caris’s AI Technology

Deal snapshot: The German biopharma will partner with Caris’s research arm to discover and validate novel targets for incorporation into first-in-class antibody-drug conjugates for cancer.

Deals Artificial Intelligence

Investor Faith In David Hung’s Nuvation Renewed By Anheart Buyout

The acquisition brings two potential best-in-class cancer therapies, which could make Nuvation a commercial company as soon as 2025.

Deals Companies

China Biotech IPO Drought Lingers But HK Sees First Of 2024

Biotech IPOs on the Chinese mainland have dried up since June 2023 due to regulatory tightening, but Hong Kong is still open to listings of pre-revenue ventures and has seen its first offering of this year.

Financing China
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Mochida Pharmaceutical Plant Co., Ltd.
    • Mochida Healthcare Co., Ltd.
UsernamePublicRestriction

Register